Psilocybin study for migraine and healthy volunteers
Treatments studied
Part of Brain & nervous system clinical trials.
This study looks at how psilocybin affects the brain in people with migraines and in healthy volunteers. The goal is to understand why it may help with headache disorders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 70 years old.
- You have migraines (diagnosed by a doctor) or you are a healthy volunteer.
- You don't have a serious or unstable medical condition (like a brain disorder).
- You are not pregnant, breastfeeding, or planning to become pregnant, and you use reliable birth control.
- You don't have a history of psychosis or manic episodes.
- You haven't used any classic psychedelics (like psilocybin, LSD, or mescaline) in the past 6 months.
- You have not used cannabis or THC products in the past 2 weeks.
- You are not taking triptans (like sumatriptan) or ditans (like lasmiditan) more than twice a week.
- You have not taken certain serotonin-affecting preventives (like amitriptyline or fluoxetine) in the past 6 weeks.
- You have not had treatments like Botox or nerve blocks that give temporary relief.
- You don't have a bleeding disorder and you are not on blood thinners (like warfarin).
- You can avoid ibuprofen, naproxen, and similar pain relievers for 7 days before and after a PET scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether very small, repeated doses of psilocybin (a substance found in certain mushrooms) can improve thinking, mood, and quality of life. It is for adults who have never used psychedelics and are in good general health, both mentally and physically.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
This research study compares brain structure and psychological traits in people with chronic migraines that don't respond well to standard treatments versus healthy volunteers without migraines. Understanding these differences may help doctors develop better treatment options for difficult-to-treat migraines.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.